Differential effects of pyrrolidine dithiocarbamate on TNF-α-mediated liver injury in two different models of fulminant hepatitis
Differential effects of pyrrolidine dithiocarbamate on TNF-α-mediated liver injury in two different models of fulminant hepatitis
复制标题
DOI:
10.1016/j.jhep.2007.10.014
复制
发表时间:
2008-03-01
影响因子:
25.7
通讯作者:
Xu, De-Xiang
中科院分区:
文献类型:
--
作者:
Lu, Jin-Wel;Wang, Hua;Xu, De-Xiang
Background/Aims: Pyrrolidine dithiocarbamate (PDTC) is an inhibitor of nuclear factor kappa B (NF-kappa B) activation. The present study aimed to investigate the effects of PDTC on lipopolysaccharide (LPS)-induced liver injury in two different models of fulminant hepatitis.Methods: Mice infected with Bacillus Calmette Guerin (BCG) were challenged with LPS (0.2 mg/kg) to induce the model of inflammatory liver injury. Mice were injected with D-galactosamine (GalN, 600 mg/kg) and LPS (20 mu g/kg) to induce the model of apoptotic liver injury. In the treatment groups, mice were pre-treated with PDTC (100 mg/kg), initiated 24 h prior to LPS.Results: PDTC pretreatment reduced the infiltration of inflammatory cells, inhibited NF-kappa B activation and the expression of tumor necrosis factor alpha (TNF-alpha), attenuated nitric oxide production, and alleviated hepatic glutathione depletion. Correspondingly, PDTC reduced serum alanine aminotransferase, improved hepatic necrosis, and prolonged the survival in the BCG/LPS model. Conversely, PDTC accelerated death and aggravated liver apoptosis in the GalN/LPS model, although it reduced nitric oxide production, attenuated glutathione depletion, and inhibited the expression of TNF-alpha in liver.Conclusions: PDTC protects mice aGalNst BCG/LPS-induced inflammatory liver injury through the repression of NF-kappa B-mediated TNF-alpha release, while it seems to be detrimental in GalN/LPS-induced apoptotic liver damage. (C) 2008 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.